About us
One of the UK’s leading commercial stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities.
The strategy is to:
- Build a profitable and cash generative business
- Develop and commercialise low development-risk late-stage products for unmet medical needs in the US
- Partner all of our NCE drug candidates
- Leverage our structure- and fragment-based drug discovery expertise via collaborations with leading pharmaceutical companies
See where Vernalis is now
View the Commercial pipeline, NCE Pipeline, plus our staffing and research capabilities
Experienced, successful, engaged leadership
For a company this size, our directors and senior management stand out
Interested in working with us?
Check out current vacancies and see the specialisations we are looking for
Clear direction for the competitive biotech sector
What therapeutic areas are we targeting, and what strategies do we rely on to achieve results?
Where does Vernalis come from?
The history of the organisation, and the relationships we’ve developed
We take our responsibilities seriously
Good governance and good practice are inherent in all our operations
Explore the pipeline ...